Chaput Y, Blier P, De Montigny C (1988) Acute and long-term effects of
antidepressant serotonin (5-HT) reuptake blockers on the efficacy of
5-HT neurotransmission: electrophysiological studies in the rat central
nervous system. In: Advances in biological psychiatry (Mendlewicz J,
van Praag HM, eds), pp 1–17. Basel: Karger.
Cochran E, Robins E, Grote S (1976) Regional serotonin levels in brain:
a comparison of depressive suicides and alcoholic suicides with controls. Biol Psychiatry 11:283–294.
Fanelli RJ, McMonagle-Strucko K (1992) Alteration of 5-HT1A receptor
binding sites following chronic treatment with ipsapirone measured by
quantitative autoradiography. Synapse 12:75– 81.
Farde L, Ginovart N, Ito H, Lundkvist C, Pike VW, McCarron JA,
Halldin C (1997) PET-characterization of [carbonyl-11C]WAY-100635
binding to 5-HT1A receptors in the primate brain. Psychopharmacology
(Berl) 133:196 –202.
Gobbi M, C avanus S, Miari A, Mennini T (1991) Effect of acute and
chronic administration of buspirone on serotonin and benzodiazepine
receptor subtypes in the rat brain: an autoradiography study. Neuropharmacology 30:313–321.
Hensler JG, Kovachich GB, Frazer A (1991) A quantitative autoradiographic study of serotonin-1A receptor regulation: effect of 5,7- dihydroxytryptamine and antidepressant treatments. Neuropsychopharmacology 4:131–144.
Invernizzi R, Bramante M, Samanin R (1994) Chronic treatment with
citalopram facilitates the effect of a challenge dose on cortical serotonin
output: role of presynaptic 5-HT1A receptors. Eur J Pharmacol
260:243–246.
Kelly TM, Mann JJ (1996) Validity of DSM-III-R diagnosis by psychological autopsy: a comparison with clinician ante-mortem diagnosis.
Acta Psychiatr Scand 94:337–343.
Korpi ER, Kleinman J, Goodman SI, Phillips I, DeLisi LE, Linnoila M,
Wyatt RJ (1986) Serotonin and 5-hydroxyindoleacetic acid in brains of
suicide victims: comparison in chronic schizophrenic patients with
suicide as cause of death. Arch Gen Psychiatry 43:594 – 600.
Le Poul E, Laaris N, Doucet E, Laporte A-M, Hamon M, Lanf umey L
(1995) Early desensitization of somato-dendritic 5-HT1A autoreceptors in rats treated with fluoxetine or paroxetine. Naunyn Schmiedebergs Arch Pharmacol 352:141–148.
Lloyd KG, Farley IJ, Deck JHN, Hornykiewicz O (1974) Serotonin and
5-hydroxyindoleacetic acid in discrete areas of the brainstem of suicide
victims and control patients. Adv Biochem Psychopharmacol
11:387–397.
Lowther S, De Paermentier F, Cheetham SC, Crompton MR, Katona
CL E, Horton RW (1997) 5-HT1A receptor binding sites in postmortem brain samples from depressed suicides and controls. J Affect
Disord 42:199 –207.
Malison RT, Pelton G, Carpenter L, Sanacora G, Haroon E, Potenza M,
Berman R, Baldwin RM, Seibyl JS, Price LH, Innis RB, Charney DS
(1997) Reduced midbrain serotonin transporter binding in depressed
vs. healthy subjects as measured by [ 123I]β-CI T SPEC T. Soc Neurosci
Abstr 23:1120.
Mann JJ, Malone K M, Sweeney JA, Brown RP, Linnoila M, Stanley B,
Stanley M (1996) Attempted suicide characteristics and cerebrospinal
fluid amine metabolites in depressed patients. Neuropsychopharmacology 15:576 –586.
Miquel MC, Doucet E, Riad M, Adrien J, Verge ́ D, Hamon M (1992)
Effect of the selective lesion of serotoninergic neurons on the regional
distribution of 5-HT1A receptor mRNA in the rat brain. Mol Brain Res
14:357–362.
Montgomery SA (1995) Selective serotonin reuptake inhibitors in the
acute treatment of depression. In: Psychopharmacology: the fourth
generation of progress (Bloom F E, Kupfer DJ, eds), pp 1043–1051.
New York: Raven.
